Managers’ Transactions

Announcements about directors’ dealings / managers´ transactions

Since July 3, 2016, the European Market Abuse Regulation N° 596 / 2014 (“MAR”) has been in force for the reporting and disclosure of transactions involving the company’s financial instruments and derivatives

The reporting and disclosure duty applies to members of the Board of Management and of the Supervisory Board, and to persons closely associated with them. It also applies to legal entities, other companies, or organizations acting by order of or in the interests of the aforementioned persons

Notifications acc. to § 15a WpHG (until July 3, 2016) and acc. to Art. 19 MAR (after July 3, 2016):

The following transactions were reported to the company from the relevant group of people:

10.10.2017Michael Schlenk
11.09.2017Michael Schlenk
11.09.2017
Dr. Wilke Management & Consulting GmbH
23.12.2016Michael Schlenk
23.12.2016Dr. Wilke Management & Consulting GmbH
23.12.2016Dr. Konstantin Rogalla
23.12.2016Richard F. Chambers
21.01.2016Michael Schlenk
20.01.2016Michael Schlenk
21.10.2015Michael Schlenk
15.10.2015Michael Schlenk
18.05.2015Michael Schlenk
31.10.2014Dr. Wilke Management & Consulting GmbH
31.10.2014Michael Schlenk
29.04.2014Melanie Rössler
05.03.2014Melanie Rössler
05.07.2013Dr. Wilke Management & Consulting GmbH
05.07.2013Dr. Wilke Management & Consulting GmbH
04.07.2013Dr. Wilke Management & Consulting GmbH
03.07.2013Dr. Wilke Management & Consulting GmbH
02.05.2013Dr. Wilke Management & Consulting GmbH
29.04.2013Dr. Wilke Management & Consulting GmbH
11.12.2012Dr. Detlef Wilke
11.12.2012Dr. Wilke & Partner Biotech Consulting GmbH
15.12.2011Hans Dieter Rössler
15.12.2011Elisabeth Rössler